Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLG) Return on Sales (2016 - 2017)

Bone Biologics (BBLG) has disclosed Return on Sales for 2 consecutive years, with 4.1% as the latest value for Q4 2017.

  • On a quarterly basis, Return on Sales fell 2112.0% to 4.1% in Q4 2017 year-over-year; TTM through Dec 2017 was 4.1%, a 2112.0% decrease, with the full-year FY2025 number at 24.72%, up 1429.0% from a year prior.
  • Return on Sales was 4.1% for Q4 2017 at Bone Biologics, down from 5.22% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 39.55% in Q1 2016 to a low of 1.06% in Q2 2017.